Magellan Health Inc  

(Public, NASDAQ:MGLN)   Watch this stock  
Find more results for MGLN
+1.03 (1.59%)
Mar 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 64.75 - 67.24
52 week 49.50 - 84.71
Open 64.75
Vol / Avg. 110,562.00/162,446.00
Mkt cap 1.55B
P/E 20.00
Div/yield     -
EPS 3.28
Shares 23.60M
Beta 0.68
Inst. own 99%
Feb 27, 2017
Q4 2016 Magellan Health Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 2.83% 1.57%
Operating margin 5.14% 3.16%
EBITD margin - 5.35%
Return on average assets 6.09% 3.36%
Return on average equity 13.18% 7.19%
Employees 9,700 -
CDP Score - -


4800 N Scottsdale Rd Ste 4400
SCOTTSDALE, AZ 85251-7680
United States - Map
+1-602-5726050 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Officers and directors

Barry Michael Smith Executive Chairman of the Board, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Mostafa Kamal Chief Executive Officer of Magellan Rx Management
Age: 35
Bio & Compensation  - Reuters
Sanjeev K. Srivastava Chief Executive Officer - Magellan Healthcare
Age: 48
Bio & Compensation  - Reuters
Caskie R. Lewis-Clapper Chief Human Resource Officer
Age: 51
Bio & Compensation  - Reuters
Srinivas Koushik Chief Technology Officer
Bio & Compensation  - Reuters
Daniel N. Gregoire General Counsel, Secretary
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William J. McBride Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
John O. Agwunobi M.D. Independent Director
Age: 51
Bio & Compensation  - Reuters
Eran Broshy Independent Director
Age: 57
Bio & Compensation  - Reuters
Michael S. Diament Independent Director
Age: 47
Bio & Compensation  - Reuters